Home Blog Page 183

Blog

Pharma Marketing Blog

Most popular

Pfizer’s Harem Styled Gulfstream G550 for Sale: US $35,500,000 (Lightly Used)

Pharma Guy - May 29, 2009

Vote for New FDA Commissioner: Let Obama Know

Pharma Guy - November 12, 2008

Disease Mongering Podcast

Pharma Guy - December 19, 2006

How Risky are Rx Drugs?

Pharma Guy - July 17, 2008

Wikis and Social Networks for Marketing & Sales Collaboration: Will It...

Pharma Guy - August 23, 2007

What’s Roche Doing on Pinterest?

Pharma Guy - December 22, 2016

Cautionary Tale About a Web-Based Tool Gone Awry

Pharma Guy - December 12, 2012

The NJ-PA Pharma “Brain Drain”

Pharma Guy - August 21, 2011

Creativity Outside of Pharma Marketing

Pharma Guy - April 11, 2008

Pfizer Facebook a la Sermo?

Pharma Guy - October 15, 2007

1...182183184...240 Page 183 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026